RWD6 COMPARATIVE ANALYSIS OF MEDICATION VALUE SETS ACROSS REFERENCE SOURCES TO ENSURE COMPLETE COVERAGE FOR REAL WORLD EVIDENCE STUDIES

Objectives: As the world transitions into the endemic phase of COVID-19, a new challenge emerges: the long-term burden of illness among survivors.Health-related quality of life (HRQoL) outcomes remains poorly understood in low-and middleincome countries, where post-pandemic policy decisions lack localized evidence.This study aimed to map the trajectory of HRQoL recovery in a large cohort of Malaysian COVID-19 survivors and identify key sociodemographic and clinical predictors-critical inputs for value-based post-COVID care and pandemic preparedness.Methods: A prospective cohort study involving 2,000 recovered patients was conducted in Selangor, Malaysia.HRQoL was assessed at three intervals-during infection, 3 months, and 6 months post-discharge, using EQ-5D-5L (utility values) and COVID-19-Quality of Life (disease-specific).The CO-19-QoL tool was culturally adapted and validated in accordance with the Professional Society for Health Economics and Outcomes Research (ISPOR) guidelines, demonstrating high internal consistency (Cronbach's =0.919) and test-retest reliability (ICC=0.896).General Linear Models and repeated measures ANOVA were used to examine HRQoL changes and associated factors.Results: EQ-5D utility scores improved from 0.33 6 0.19 (baseline) to 0.54 6 0.20 (6 months; p,0.001), and EQ-VAS scores rose from 45.50 to 86.38.CO-19-QoL scores declined from 19.49 to 1.89, indicating reduced symptom burden.However, recovery was uneven.Poorer HRQoL trajectories were significantly associated with older age ($ 60), comorbidities, lower education, private sector employment, overweight BMI, smoking, and severe COVID-19 (Category 4).Socioeconomic disparities were evident; low-income patients (B40) experienced the slowest recovery (p,0.001).Conclusions: While overall HRQoL improved, vulnerable groups faced persistent deficits, highlighting the need for targeted post-COVID rehabilitation and equity-driven policies.EQ-5D-derived utility values lay the groundwork for cost-utility analyses and health technology assessments in Malaysia.These findings provide critical evidence for post-pandemic planning and reinforce the importance of integrating HRQoL into future emergency preparedness frameworks.

Authors

Institutions

Publication Details

Journal
Value in Health Regional Issues
Published
2025-10-01
DOI
https://doi.org/10.1016/j.vhri.2025.101185
Primary Topic
Health Systems, Economic Evaluations, Quality of Life
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

RWD6 COMPARATIVE ANALYSIS OF MEDICATION VALUE SETS ACROSS REFERENCE SOURCES TO ENSURE COMPLETE COVERAGE FOR REAL WORLD EVIDENCE STUDIES

Michael D. Buck, Aaron Kamauu, Craig G. Parker, Jared H. Kamauu
Value in Health Regional Issues
Health Systems, Economic Evaluations, Quality of Life
article

RWD6 COMPARATIVE ANALYSIS OF MEDICATION VALUE SETS ACROSS REFERENCE SOURCES TO ENSURE COMPLETE COVERAGE FOR REAL WORLD EVIDENCE STUDIES

Michael D. Buck, Aaron Kamauu, Craig G. Parker, Jared H. Kamauu
article en

Abstract

Objectives: As the world transitions into the endemic phase of COVID-19, a new challenge emerges: the long-term burden of illness among survivors.Health-related quality of life (HRQoL) outcomes remains poorly understood in low-and middleincome countries, where post-pandemic policy decisions lack localized evidence.This study aimed to map the trajectory of HRQoL recovery in a large cohort of Malaysian COVID-19 survivors and identify key sociodemographic and clinical predictors-critical inputs for value-based post-COVID care and pandemic preparedness.Methods: A prospective cohort study involving 2,000 recovered patients was conducted in Selangor, Malaysia.HRQoL was assessed at three intervals-during infection, 3 months, and 6 months post-discharge, using EQ-5D-5L (utility values) and COVID-19-Quality of Life (disease-specific).The CO-19-QoL tool was culturally adapted and validated in accordance with the Professional Society for Health Economics and Outcomes Research (ISPOR) guidelines, demonstrating high internal consistency (Cronbach's =0.919) and test-retest reliability (ICC=0.896).General Linear Models and repeated measures ANOVA were used to examine HRQoL changes and associated factors.Results: EQ-5D utility scores improved from 0.33 6 0.19 (baseline) to 0.54 6 0.20 (6 months; p,0.001), and EQ-VAS scores rose from 45.50 to 86.38.CO-19-QoL scores declined from 19.49 to 1.89, indicating reduced symptom burden.However, recovery was uneven.Poorer HRQoL trajectories were significantly associated with older age ($ 60), comorbidities, lower education, private sector employment, overweight BMI, smoking, and severe COVID-19 (Category 4).Socioeconomic disparities were evident; low-income patients (B40) experienced the slowest recovery (p,0.001).Conclusions: While overall HRQoL improved, vulnerable groups faced persistent deficits, highlighting the need for targeted post-COVID rehabilitation and equity-driven policies.EQ-5D-derived utility values lay the groundwork for cost-utility analyses and health technology assessments in Malaysia.These findings provide critical evidence for post-pandemic planning and reinforce the importance of integrating HRQoL into future emergency preparedness frameworks.

Value in Health Regional IssuesVol. 49
Navigen (United States) (US)
Openalex Percentile: Top 59%
Health Systems, Economic Evaluations, Quality of Life
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.